General Information of DTT (ID: TT7KNZQ)

DTT Name Thymidine kinase 2 (Mt-TK2) DTT Info
Gene Name dnk

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
MT-1621 DMUNBMA Thymidine kinase 2 deficiency 5C55.1 Phase 3 [1]
------------------------------------------------------------------------------------
3 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
1-[(Z)-4-(triphenylmethoxy)-2-butenyl]thymine DMU3VWA Discovery agent N.A. Investigative [2]
1-[5-(triphenylmethoxy)pentyl]thymine DMFHBJM Discovery agent N.A. Investigative [2]
1-[6-(triphenylmethoxy)hexyl]thymine DM5NVHO Discovery agent N.A. Investigative [2]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Clinical pipeline report, company report or official report of Modis Therapeutics.
2 N1-substituted thymine derivatives as mitochondrial thymidine kinase (TK-2) inhibitors. J Med Chem. 2006 Dec 28;49(26):7766-73.